Filing Details

Accession Number:
0001209191-21-065656
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-11-18 20:10:36
Reporting Period:
2021-11-16
Accepted Time:
2021-11-18 20:10:36
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1817229 Vor Biopharma Inc. VOR () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1664281 Kush Parmar C/O Vor Biopharma Inc.
100 Cambridgepark Drive, Suite 400
Cambridge MA 02140
Yes No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2021-11-16 238,870 $15.30 4,595,089 No 4 S Indirect See footnote
Common Stock Disposition 2021-11-16 91,836 $15.30 1,766,634 No 4 S Indirect See footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect See footnote
No 4 S Indirect See footnote
Footnotes
  1. The shares are directly held by 5AM Ventures VI, L.P. 5AM Partners VI, LLC is the general partner of 5AM Ventures VI, L.P. The ReportingPerson is a managing member of 5AM Partners VI, LLC, and may be deemed to share voting and dispositive power over the shares held by 5AMVentures VI, L.P. The reporting person disclaims beneficial ownership of the reported securities, except to the extent of his pecuniary interesttherein.
  2. The shares are directly held by 5AM Opportunities I, L.P. 5AM Opportunities I (GP), LLC is the general partner of 5AM Opportunities I, L.P. TheReporting Person is a managing member of 5AM Opportunities I (GP), LLC, and may be deemed to share voting and dispositive power over theshares held by 5AM Opportunities I, L.P. The reporting person disclaims beneficial ownership of the reported securities, except to the extent ofhis pecuniary interest therein.